LIVE - IC-OS Case Review Webinar - December 2021 - Practical Considerations in Cardio-Oncology Drug Interactions: A Case-Based Series
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer...
Read More
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimizing the cardiac status of patients with cancer before, during and after their treatment, we are collectively improving the overall outcomes including survival and quality of life. We aim to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Speakers
Dr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts...
Dr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor response, novel cardiac biomarkers as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. His current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis. He is the Principal Investigator of the PROTECT study looking at cardiac safety in patients undergoing proteasome inhibitor treatment for relapsed multiple myeloma and the recently completed PREDICT study, a large multicenter prospective study examining the role of cardiac biomarkers for the detection of cardiotoxicity during anthracycline based therapy. In addition, he is intimately involved in the latest treatment trials for cardiac amyloidosis. He was recently at Washington University in St Louis to enhance and expand the Cardio-Oncology Center of Excellence. He is at the forefront of concerted efforts to develop a viable Cardio-Oncology fellowship training program and continues to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world. He is the current President of the International Cardio-Oncology Society (ICOS),www.IC-OS.org, which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
Dr. Rodgers is currently a professor at UNC Eshelman School of PHarmacy where she serves Director of Postgraduate...
Dr. Rodgers is currently a professor at UNC Eshelman School of PHarmacy where she serves Director of Postgraduate Education. She is board certified in both cardiology and pharmacotherapy and is a fellow of the American College of Clinical Pharmacy, the Heart Failure Society of America, and the American Heart Association.
Preston Skersick is a first-year U.S. Medical Affairs Fellow with the University of North Carolina and...
Preston Skersick is a first-year U.S. Medical Affairs Fellow with the University of North Carolina and GlaxoSmithKline. Originally from Indiana, Preston spent the last 10 years in the state of Georgia where he received his Bachelors of Science in Chemistry from Georgia College & State University. In May of 2021, he graduated from the Mercer University College of Pharmacy in Atlanta, GA with his Doctorate of Pharmacy. The first year of Preston’s fellowship has focused on cardiology and cardio-oncology.
Sarah is a Board-Certified Oncology Pharmacist at North Memorial Health Care in Minneapolis, MN. She is passionate...
Sarah is a Board-Certified Oncology Pharmacist at North Memorial Health Care in Minneapolis, MN. She is passionate about patient-directed cancer care and late-breaking research in clinical pharmacy, inpatient supportive care, and Hematology/Oncology practice. She completed her PGY-2 Hematology/Oncology Residency at the University of Minnesota Medical Center and serves as a lecturer at the University of Minnesota College of Pharmacy.